Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation

被引:14
|
作者
Grat, Karolina [1 ]
Pacho, Ryszard [1 ]
Grat, Michal [2 ]
Krawczyk, Marek [2 ]
Zieniewicz, Krzysztof [2 ]
Rowinski, Olgierd [1 ]
机构
[1] Med Univ Warsaw, Dept Clin Radiol 2, PL-02097 Warsaw, Poland
[2] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, PL-02097 Warsaw, Poland
关键词
obesity; hepatocellular carcinoma; liver transplantation; subcutaneous fat; visceral fat; computed tomography; adipose tissue; sarcopenia; VISCERAL ADIPOSITY; GASTRIC-CANCER; SARCOPENIA; OBESITY; RESECTION; OUTCOMES; HEPATECTOMY; PROGNOSIS; SURVIVAL; LEPTIN;
D O I
10.3390/jcm8101672
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Body composition parameters are reported to influence the risk of hepatocellular carcinoma (HCC) recurrence after liver resection, yet data on patients undergoing liver transplantation are scarce. The aim of this study was to evaluate the impact of the amount of abdominal adipose tissue and skeletal muscles on the risk of HCC recurrence after liver transplantation. Methods: This was a retrospective observational study performed on 77 HCC patients after liver transplantation. Subcutaneous fat area (SFA), visceral fat area, psoas muscle area and total skeletal muscle area were assessed on computed tomography on the level of L3 vertebra and divided by square meters of patient height. The primary outcome measure was five-year recurrence-free survival. Results: Recurrence-free survival in the entire cohort was 95.7%, 90.8%, and 86.5% after one, three, and five years post-transplantation, respectively. SFA was significantly associated with the risk of HCC recurrence (p = 0.013), whereas no significant effects were found for visceral fat and skeletal muscle indices. The optimal cut-off for SFA for prediction of recurrence was 71.5 cm(2)/m(2). Patients with SFA < 71.5 cm(2)/m(2) and >= 71.5 cm(2)/m(2) exhibited five-year recurrence-free survival of 96.0% and 55.4%, respectively (p = 0.001). Conclusions: Excessive amount of subcutaneous adipose tissue is a risk factor for HCC recurrence after liver transplantation and may be considered in patient selection process.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Impact of Graft Regeneration to the Recurrence of Hepatocellular Carcinoma after Living Donor Liver Transplantation
    Lee, Su Hyung
    Joo, Dong Jin
    Kim, Myoung Soo
    Han, Dai Hoon
    Lee, Hyung Soon
    Huh, Kyu Ha
    Choi, Gi Hong
    Choi, Jin Sub
    Kim, Soon Il
    LIVER TRANSPLANTATION, 2013, 19 : S271 - S271
  • [42] Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
    Lee, Okjoo
    Rhu, Jinsoo
    Choi, Gyu-Seong
    Kim, Jong Man
    Kim, Kyunga
    Joh, Jae-Won
    ANNALS OF TRANSPLANTATION, 2022, 27
  • [43] Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma
    Decaens, T
    Roudot-Thoraval, F
    Bresson-Hadni, S
    Meyer, C
    Gugenheim, J
    Durand, F
    Bernard, PH
    Boillot, O
    Boudjema, K
    Calmus, Y
    Hardwigsen, J
    Ducerf, C
    Pageaux, GP
    Dharancy, S
    Chazouilleres, O
    Dhumeaux, D
    Cherqui, D
    Duvoux, C
    LIVER TRANSPLANTATION, 2005, 11 (07) : 767 - 775
  • [44] CONDITIONAL COMPETING RISK OF TUMOR RECURRENCE AFTER LIVER TRANSPLANTATION OF PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Vitale, Alessandro
    Valli, Valeria
    Moustafa, Mohamed
    Buroni, Elia
    D'amico, Francesco
    Gringeri, Enrico
    Bassi, Domenico
    Neri, Daniele
    Zanus, Giacomo
    Burra, Patrizia
    Mescoli, Claudia
    TRANSPLANT INTERNATIONAL, 2015, 28 : 88 - 88
  • [45] Systematic review: risk prediction models for recurrence of hepatocellular carcinoma after liver transplantation
    Al-Ameri, Abdulahad Abdulrab Mohammed
    Wei, Xuyong
    Wen, Xue
    Wei, Qiang
    Guo, Haijun
    Zheng, Shusen
    Xu, Xiao
    TRANSPLANT INTERNATIONAL, 2020, 33 (07) : 697 - 712
  • [46] Analysis of Risk Factors for Recurrence and Metastasis in Patients with Hepatocellular Carcinoma after Liver Transplantation
    Zhang Hua
    Wang Wei
    Guan Qin
    Zhai Zhen-guo
    Li Xin
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (03): : 209 - 213
  • [47] Incidence and Risk Factors of Hepatocellular Carcinoma Recurrence After Liver Transplantation in the MELD Era
    Sharma, Pratima
    Welch, Kathy
    Hussain, Hero
    Pelletier, Shawn J.
    Fontana, Robert J.
    Marrero, Jorge
    Merion, Robert M.
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (03) : 806 - 812
  • [48] Risk Factors of Tumor Recurrence After Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma
    Park, Woong Ki
    Joshi, Pravin Kumar
    Lee, Kwang-Woong
    Lee, Kyoung Bun
    Hong, Suk Kyun
    Yoon, Kyung Chul
    Lee, Jeong-Moo
    Cho, Jae-Hyung
    Yi, Nam-Joon
    Suh, Kyung-Suk
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (01) : 271 - 275
  • [49] Incidence and Risk Factors of Hepatocellular Carcinoma Recurrence After Liver Transplantation in the MELD Era
    Pratima Sharma
    Kathy Welch
    Hero Hussain
    Shawn J. Pelletier
    Robert J. Fontana
    Jorge Marrero
    Robert M. Merion
    Digestive Diseases and Sciences, 2012, 57 : 806 - 812
  • [50] Does graft hemodynamics affect the risk of hepatocellular carcinoma recurrence after liver transplantation?
    Matsushima, Hajime
    Acevedo-Moreno, Lou-Anne
    Sasaki, Kazunari
    Fujiki, Masato
    Kwon, Choon Hyuck David
    Uso, Teresa Diago
    D'Amico, Giuseppe
    Aucejo, Federico
    Eghtesad, Bijan
    Miller, Charles
    Quintini, Cristiano
    Hashimoto, Koji
    CLINICAL TRANSPLANTATION, 2020, 34 (08)